Emergent BioSolutions Reports Financial Results for Full Year 2008.
Business Wire › March 05, 2009
Linked as:
Extract
Emergent BioSolutions Reports Financial Results for Full Year 2008.
* 2008 total revenues of $178.6 million and net income of $20.7 million, or $0.69 per share, representing seventh consecutive year of profitability
* December 31, 2008 cash and cash equivalents of $91.5 million * 2009 financial guidance, excluding potential contribution of rPA contract with HHS, anticipates revenue growth of 25% to 35% to approximately $225 to $240 million and net income in excess of $20 million ROCKVILLE, Md. -- Emergent BioSolutions Inc. (NYSE:EBS) announced today its financial results for the fourth quarter and full year ended December 31, 2008. For the full year...See the full content of this document
Sponsored links
